FdaApplication
ANDA 213471
Identifiers
- fda_app_no: ANDA213471
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2020-02-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | EQ 4MG BASE/PACKET | GRANULE;ORAL |
1 product